Molecular Biological Determination of HER2 Status Using Both DNA and RNA Approaches: A Concordance Study with IHC Assessment
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26052148 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Ema Ruszova und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Clinical Genetics, University Hospital Bulovka, 180 81 Prague, Czech Republic. Hauptthemen laut MEDLINE: Erb-b2 Receptor Tyrosine Kinases, Breast Neoplasms, RNA, DNA. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Charles University, Third Faculty of Medicine, Charles University, Prague, Czech Republic.
Abstract (Originalsprache)
The immunohistochemical (IHC) or fluorescence/chromogenic in situ hybridization (FISH/CISH) assays for assessing HER2 are now recommended by the American Society of Clinical Oncologists and the College of American Pathologists, but there are an increasing number of published studies describing alternative diagnoses at the molecular level. Inspired by these studies, we established a laboratory-developed test (LDT) to analyze HER2 status not only at the gene expression level but also at the gene copy number. A precise copy number calculation was fulfilled including the Control Genomic DNA of known concentration, which allowed subsequent assay validation at the DNA level. The results were reported according to the concordant results of the DNA and RNA approaches. By comparing with IHC determination, completely identical results were found in ten blank samples, which underlines the legitimacy of molecular biological approaches in this diagnostic field. An equivocal sample that was positive by IHC and qPCR was found to be negative by the FISH and so it may change the choice of personalized medicine. The topic of this short communication will hopefully contribute to allowing IVD-certified diagnostics based on the HER2 gene expression profile or copy number to be tested in the Czech Republic as well.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Clinical Genetics, University Hospital Bulovka, 180 81 Prague, Czech Republic.
- The Central Laboratories, University Hospital Bulovka, 180 81 Prague, Czech Republic.
- Third Faculty of Medicine, Charles University, 100 00 Prague, Czech Republic.
- Department of Anatomical Pathology, University Hospital Bulovka, 180 81 Prague, Czech Republic.
ORCID-Profile: Ema Ruszova
Förderung
- Charles University
- Third Faculty of Medicine, Charles University, Prague, Czech Republic
Zitieren
APA
Ruszova, E., Khaznadar, Z., Spurkova, Z., & Vlcanova, K. (2025). Molecular Biological Determination of HER2 Status Using Both DNA and RNA Approaches: A Concordance Study with IHC Assessment. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26052148
Vancouver
Ruszova E, Khaznadar Z, Spurkova Z, Vlcanova K. Molecular Biological Determination of HER2 Status Using Both DNA and RNA Approaches: A Concordance Study with IHC Assessment. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26052148
BibTeX
@article{Ruszova2025,
author = {Ruszova, Ema and Khaznadar, Ziad and Spurkova, Zuzana and Vlcanova, Katerina},
title = {Molecular Biological Determination of HER2 Status Using Both DNA and RNA Approaches: A Concordance Study with IHC Assessment},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26052148}
}
EUVIMED